(Q54384006)
Statements
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial (English)
1 reference
1 reference
R. L. Miller
R. M. Bukowski
G. T. Budd
J. Purvis
J. K. Weick
K. Shepard
K. K. Midha
1 May 1988
1 reference
6
1 reference
880-888
1 reference
5
1 reference
Identifiers
1 reference